The case for ablating nondysplastic Barrett’s esophagus - 16/10/14
Doi : 10.1016/j.gie.2014.06.010
Robert A. Ganz, MD, FASGE 1, 2, ⁎, Benjamin Mitlyng, MD 1, Sam Leon, MD 1
1 Minnesota Gastroenterology, PA, Plymouth, Minnesota, USA
2 University of Minnesota, Minneapolis, Minnesota, USA
∗Reprint requests: Robert A. Ganz, MD, FASGE, Minnesota Gastroenterology, PA, Associate Professor of Medicine, University of Minnesota, 15700 37th Avenue North, #300, Plymouth, MN 55446.
Abbreviations : BE, ER, NNT, RFA
Plan
| DISCLOSURE: R. Ganz is the inventor of balloon-based radiofrequency ablation and cofounder of BARRX Medical, Inc. In the past, the author received equity and honoraria from Covidien, Inc but has no current conflicts and does not anticipate any in the future. No other financial relationships relevant to this article were disclosed. |
© 2014
American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 80 - N° 5
P. 866-872 - novembre 2014 Retour au numéro
Article précédent
- Continuing Medical Education Exam: November 2014
- James Buxbaum, William Ross, Shou-Jiang Tang, Brian Weston, G.S. Raju, Glenn M. Eisen
- Radiofrequency ablation for nondysplastic Barrett’s esophagus: certainly not for all
- Charles J. Lightdale
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?